Innovative Medicine
-
FDA Approves EDURANT™ (rilpivirine) For Use in Treatment-Naïve Adults with HIV-1
Third medication for Tibotec Therapeutics HIV treatment portfolio -
-
“Living with Schizophrenia” Documentary Shines Spotlight on People with Schizophrenia: A Misunderstood and Stigmatized Illness
Film provides powerful insights through compelling first-person life stories -
New Phase 3 Study Results Show REMICADE® is Effective in the Treatment of Pediatric Patients With Moderate to Severe Ulcerative Colitis
Study Findings Demonstrate Clinical Response with REMICADE in Pediatric Patients Who Have Not Responded to Conventional Therapy -
Phase 2b Data Show Treatment With STELARA® Induced and Maintained Clinical Response in Patients With Moderate to Severe Crohn’s Disease
Study Findings Show Efficacy of STELARA in Patients Who Previously Had Inadequate Response to Tumor Necrosis Factor Antagonists -
-
ZYTIGA™ (Abiraterone Acetate) Receives FDA Approval For Treatment Of Metastatic Prostate Cancer After Priority Review
First Once-Daily, Oral Treatment for Metastatic Prostate Cancer Inhibits Androgen Production at All Three Sources -
Rivaroxaban Successfully Demonstrated Non-Inferiority Compared to Standard of Care for the Prevention of Recurrent Venous Thromboembolism in Pivotal Phase 3 Study
Latest Results from EINSTEIN Program Presented at European Society of Cardiology Congress -